» Articles » PMID: 16532004

A Novel Prognostic Subtype of Human Hepatocellular Carcinoma Derived from Hepatic Progenitor Cells

Overview
Journal Nat Med
Date 2006 Mar 15
PMID 16532004
Citations 444
Authors
Affiliations
Soon will be listed here.
Abstract

The variability in the prognosis of individuals with hepatocellular carcinoma (HCC) suggests that HCC may comprise several distinct biological phenotypes. These phenotypes may result from activation of different oncogenic pathways during tumorigenesis and/or from a different cell of origin. Here we address whether the transcriptional characteristics of HCC can provide insight into the cellular origin of the tumor. We integrated gene expression data from rat fetal hepatoblasts and adult hepatocytes with HCC from human and mouse models. Individuals with HCC who shared a gene expression pattern with fetal hepatoblasts had a poor prognosis. The gene expression program that distinguished this subtype from other types of HCC included markers of hepatic oval cells, suggesting that HCC of this subtype may arise from hepatic progenitor cells. Analyses of gene networks showed that activation of AP-1 transcription factors in this newly identified HCC subtype might have key roles in tumor development.

Citing Articles

Folate receptor 1 is a stemness trait-associated diagnostic and prognostic marker for hepatocellular carcinoma.

Shiode Y, Kodama T, Sato Y, Takahashi R, Matsumae T, Shirai K Biomark Res. 2025; 13(1):37.

PMID: 40038575 PMC: 11877696. DOI: 10.1186/s40364-025-00752-8.


The Clinical Characteristics, Patterns of Recurrence, and Long-Term Survival Outcomes of Dual-Phenotype Hepatocellular Carcinoma After Curative Liver Resection.

Yu Z, Fang Z, Yu Y, Liu S, Wang K, Shi Z J Hepatocell Carcinoma. 2025; 12:183-192.

PMID: 39902378 PMC: 11789503. DOI: 10.2147/JHC.S493094.


Digestive cancers: mechanisms, therapeutics and management.

Zhan T, Betge J, Schulte N, Dreikhausen L, Hirth M, Li M Signal Transduct Target Ther. 2025; 10(1):24.

PMID: 39809756 PMC: 11733248. DOI: 10.1038/s41392-024-02097-4.


CK19 protein expression: the best cutoff value on the prognosis and the prognosis model of hepatocellular carcinoma.

Yang C, Xiang W, Wu Z, Li N, Xie G, Huang J BMC Cancer. 2025; 25(1):55.

PMID: 39789507 PMC: 11720332. DOI: 10.1186/s12885-024-13399-9.


RAGE is a key regulator of ductular reaction-mediated fibrosis during cholestasis.

Lam W, Gabernet G, Poth T, Sator-Schmitt M, Oquendo M, Kast B EMBO Rep. 2025; 26(3):880-907.

PMID: 39747668 PMC: 11811172. DOI: 10.1038/s44319-024-00356-7.